HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Transport ATPases of cardiac sarcolemma in 20,25-diazacholesterol induced myopathy.

Abstract20,25-Diazacholesterol, known to induce myotonia in skeletal muscle, also affects cardiac muscle as can be concluded from the development of cardiomegaly. At the same time (Na+, K+) ATPase of cardiac sarcolemmal membranes of the 20,25-diazacholesterol treated rats showed an increased activity as compared with control animals (91 percent and 46 percent stimulation respectively). The Ca++ stimulated ATPase showed the same tendency (96 percent and 64 percent stimulation). In the plasma of the treated rats creatine phosphokinase activity was found to be elevated whereas the amount of protein-bound iodine was decreased, a finding that is common in myotonic dystrophy.
AuthorsW Fiehn, D Seiler, E Kuhn, D Bartels
JournalEuropean journal of clinical investigation (Eur J Clin Invest) Vol. 5 Issue 4 Pg. 327-30 (Jul 29 1975) ISSN: 0014-2972 [Print] GERMANY, WEST
PMID126165 (Publication Type: Journal Article)
Chemical References
  • Aza Compounds
  • Desmosterol
  • Cholesterol
  • Adenosine Triphosphatases
Topics
  • Adenosine Triphosphatases (metabolism)
  • Animals
  • Aza Compounds
  • Biological Transport
  • Body Weight
  • Cardiomegaly (chemically induced, enzymology)
  • Cholesterol (adverse effects, analogs & derivatives, pharmacology)
  • Desmosterol (metabolism)
  • Female
  • Myocardium (enzymology)
  • Myotonia (chemically induced)
  • Organ Size
  • Rats
  • Sarcolemma (enzymology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $45.00 USD